Literature DB >> 12853628

Biochemical properties of phosphonoacetate and thiophosphonoacetate oligodeoxyribonucleotides.

David Sheehan1, Benjamin Lunstad, Christina M Yamada, Brian G Stell, Marvin H Caruthers, Douglas J Dellinger.   

Abstract

Phosphorus-modified phosphonoacetate and thiophosphonoacetate oligodeoxyribonucleotides were chemically synthesized and their biochemical properties evaluated. Under physiological pH, these DNA analogs possess negative charge and form stable, complementary A-like DNA:RNA heteroduplexes when analyzed via circular dichroism spectroscopy. Phosphonoacetate and thiophosphonoacetate oligomers were found to stimulate RNase H activity and to be completely resistant to degradation by snake venom phosphodiesterase, DNase I and HeLa cell nuclear extract. Further research has demonstrated that neutral, esterified forms of these analogs can be taken up by cells. Phosphonoacetate and thiophosphonoacetate oligomers therefore represent a new class of oligodeoxyribonucleotide analogs having phosphorus- carbon bonds with considerable potential for use in biological research.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12853628      PMCID: PMC165954          DOI: 10.1093/nar/gkg439

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  21 in total

Review 1.  Molecular mechanisms of action of antisense drugs.

Authors:  S T Crooke
Journal:  Biochim Biophys Acta       Date:  1999-12-10

2.  RNase H mediated cleavage of RNA by cyclohexene nucleic acid (CeNA).

Authors:  B Verbeure; E Lescrinier; J Wang; P Herdewijn
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

Review 3.  Phosphorothioate oligodeoxynucleotides: what is their origin and what is unique about them?

Authors:  F Eckstein
Journal:  Antisense Nucleic Acid Drug Dev       Date:  2000-04

4.  Studies on polynucleotides. LXXXVII. The joining of short deoxyribopolynucleotides by DNA-joining enzymes.

Authors:  N K Gupta; E Ohtsuka; H Weber; S H Chang; H G Khorana
Journal:  Proc Natl Acad Sci U S A       Date:  1968-05       Impact factor: 11.205

5.  The influence of antisense oligonucleotide-induced RNA structure on Escherichia coli RNase H1 activity.

Authors:  W F Lima; V Mohan; S T Crooke
Journal:  J Biol Chem       Date:  1997-07-18       Impact factor: 5.157

6.  Lipophilic pro-oligonucleotides are rapidly and efficiently internalized in HeLa cells.

Authors:  E Vivès; C Dell'Aquila; J C Bologna; F Morvan; B Rayner; J L Imbach
Journal:  Nucleic Acids Res       Date:  1999-10-15       Impact factor: 16.971

7.  Prooligonucleotides exhibit less serum-protein binding than phosphodiester and phosphorothioate oligonucleotides.

Authors:  G Tosquellas; A Bryksin; K Alvarez; F Morvan; J J Vasseur; B Rayner; E Rykova; P Laktionov; V Vlassov; J L Imbach
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2000 May-Jun       Impact factor: 1.381

8.  Synthesis of d(GC) and d(CG) octamers containing alternating phosphorothioate linkages: effect of the phosphorothioate group on the B-Z transition.

Authors:  R Cosstick; F Eckstein
Journal:  Biochemistry       Date:  1985-07-02       Impact factor: 3.162

9.  Solid-phase chemical synthesis of phosphonoacetate and thiophosphonoacetate oligodeoxynucleotides.

Authors:  Douglas J Dellinger; David M Sheehan; Nanna K Christensen; James G Lindberg; Marvin H Caruthers
Journal:  J Am Chem Soc       Date:  2003-01-29       Impact factor: 15.419

Review 10.  Modified oligonucleotides: synthesis and strategy for users.

Authors:  S Verma; F Eckstein
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

View more
  9 in total

Review 1.  Anti-miRNA oligonucleotides: A comprehensive guide for design.

Authors:  Joana Filipa Lima; Laura Cerqueira; Ceu Figueiredo; Carla Oliveira; Nuno Filipe Azevedo
Journal:  RNA Biol       Date:  2018-03-23       Impact factor: 4.652

2.  Effect of 2'-O-methyl/thiophosphonoacetate-modified antisense oligonucleotides on huntingtin expression in patient-derived cells.

Authors:  Masayuki Matsui; Richard N Threlfall; Marvin H Caruthers; David R Corey
Journal:  Artif DNA PNA XNA       Date:  2014-12-15

3.  Covalently attached intercalators restore duplex stability and splice-switching activity to triazole-modified oligonucleotides.

Authors:  Anna Dysko; Ysobel R Baker; Graham McClorey; Matthew J A Wood; Sabine Fenner; Glynn Williams; Afaf El-Sagheer; Tom Brown
Journal:  RSC Chem Biol       Date:  2022-05-16

4.  MicroRNAs Regulating Autophagy in Neurodegeneration.

Authors:  Qingxuan Lai; Nikolai Kovzel; Ruslan Konovalov; Ilya A Vinnikov
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.

Authors:  Jesper B Bramsen; Jørgen Kjems
Journal:  Front Genet       Date:  2012-08-20       Impact factor: 4.599

6.  A New 1,5-Disubstituted Triazole DNA Backbone Mimic with Enhanced Polymerase Compatibility.

Authors:  Sven Epple; Aman Modi; Ysobel R Baker; Ewa Wȩgrzyn; Diallo Traoré; Przemyslaw Wanat; Agnes E S Tyburn; Arun Shivalingam; Lapatrada Taemaitree; Afaf H El-Sagheer; Tom Brown
Journal:  J Am Chem Soc       Date:  2021-09-21       Impact factor: 15.419

7.  5'-O-Methylphosphonate nucleic acids--new modified DNAs that increase the Escherichia coli RNase H cleavage rate of hybrid duplexes.

Authors:  Hana Šipova; Tomaš Špringer; Dominik Rejman; Ondřej Šimak; Magdalena Petrová; Pavel Novák; Šarka Rosenbergová; Ondřej Páv; Radek Liboska; Ivan Barvík; Josef Štěpanek; Ivan Rosenberg; Jiři Homola
Journal:  Nucleic Acids Res       Date:  2014-02-12       Impact factor: 16.971

8.  Short-interference RNAs: becoming medicines.

Authors:  Tamara Martínez; Ana Isabel Jiménez; Covadonga Pañeda
Journal:  EXCLI J       Date:  2015-06-15       Impact factor: 4.068

9.  Transport Oligonucleotides-A Novel System for Intracellular Delivery of Antisense Therapeutics.

Authors:  Oleg V Markov; Anton V Filatov; Maxim S Kupryushkin; Ivan V Chernikov; Olga A Patutina; Anton A Strunov; Elena L Chernolovskaya; Valentin V Vlassov; Dmitrii V Pyshnyi; Marina A Zenkova
Journal:  Molecules       Date:  2020-08-11       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.